Boc-D-Allyglycine.DCHA is a protected amino acid derivative featuring an allyl-substituted glycine backbone in the D stereochemical form, with the alpha-amino group masked as a Boc (tert-butoxycarbonyl) carbamate. The molecule bears a free carboxyl group and an allyl side chain that provides an alkene functional handle for subsequent chemical modification, while DCHA indicates association with dicyclohexylamine as a counterion for the salt form. In peptide and amino acid synthesis workflows, the Boc-protected amine supports stepwise coupling by reducing undesired side reactions at the amino functionality, and the allyl group can be retained for downstream functionalization in chemical biology and conjugation-oriented derivative preparation.
Boc-D-Allyglycine.DCHA is a protected D-amino acid building block where the alpha-amino group is protected as a Boc carbamate, and the side chain contains an allyl functionality that can be carried forward into downstream peptide or medicinal chemistry sequences. The DCHA component indicates association with dicyclohexylamine (DCHA), a counterion form commonly used to improve handling and crystallinity of protected amino acid reagents. This combination makes the material particularly useful for preparing stereochemically defined peptide segments and for constructing allyl-bearing intermediates that can be further functionalized after incorporation.
1. Solid-Phase Peptide Building
Boc-D-Allyglycine.DCHA is used by peptide synthesis groups to assemble stereodefined peptide segments on solid support, where the Boc protection supports standard protected-amino-acid workflows and the D-configuration helps control backbone stereochemistry in non-natural peptide designs. The allyl side chain provides a convenient handle for later diversification, enabling synthesis strategies where side-chain modification is deferred until after the peptide scaffold is formed. This reagent is frequently selected for custom peptide manufacturing and academic peptide chemistry projects that require incorporation of an allyl-functionalized, stereochemically specified residue.
2. Peptidomimetic And SAR Intermediates
Boc-D-Allyglycine.DCHA serves as a practical intermediate for peptidomimetic development and structure-activity relationship (SAR) studies, especially when an allyl-bearing side chain is needed as a synthetic "platform" for subsequent derivatization. Medicinal chemistry teams use this type of protected D-amino acid to generate defined fragments that can be converted into substituted alkyl, alkenyl, or cyclized motifs after the core scaffold is assembled. The D-configuration and Boc protection help maintain structural fidelity through multi-step sequence construction, supporting iterative library synthesis where consistent residue identity is essential.
3. Allyl Functionalization For Derivatization
Boc-D-Allyglycine.DCHA is applied in workflows that require an allyl group as a downstream chemical handle, including post-assembly derivatization of peptide intermediates and synthesis of allyl-containing small-molecule fragments. Researchers often choose this reagent when they want to introduce an alkene-bearing side chain in a controlled, stereochemically defined manner, then convert it later to more functional substituents appropriate for binding studies, conjugation chemistry, or material-reactive motifs. The protected amino acid form supports clean incorporation into larger structures before the allyl group is transformed, reducing the risk of unwanted side reactions during earlier assembly steps.
4. Pharmaceutical Intermediate Fragment Synthesis
Boc-D-Allyglycine.DCHA is used in pharmaceutical intermediate development as a chiral, protected amino acid fragment for building defined stereocenters in complex synthetic routes. Process and development chemists select this reagent when they need an allyl-functionalized D-amino acid motif that can be carried through as a stable intermediate and then elaborated into higher-value intermediates for downstream synthesis. The Boc-protected functionality supports controlled handling during fragment coupling and purification, while the DCHA salt form is commonly used to improve practical reagent handling in industrial and contract development settings.
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More